Repligen Corp. (RGEN)

169.97 +6.64 (+4.07%) USD  |  NASDAQ  |  Jan 21, 16:00
169.73 -0.24 (-0.14%) After-Hours: 20:00
More

Repligen Stock Based Compensation (Per Share Quarterly)

Stock Based Compensation (Per Share Quarterly) Chart

View Stock Based Compensation (Per Share Quarterly) for RGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Per Share Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Per Share Quarterly) Range, Past 5 Years

View Stock Based Compensation (Per Share Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Per Share Quarterly) Benchmarks

View Stock Based Compensation (Per Share Quarterly) Benchmarks
Start Trial
Enovis Corp. Upgrade
Perspective Therapeutics, Inc. Upgrade
InfuSystem Holdings, Inc. Upgrade
Xtant Medical Holdings, Inc. Upgrade
VolitionRX Ltd. Upgrade